European Journal of Surgical Oncology
Volume 36, Issue 4 , Pages 378-383, April 2010

Total femur replacement: Primary procedure for treatment of malignant tumours of the femur

  • S. Kalra

      Affiliations

    • Royal Orthopaedic Hospital NHS Trust, Bristol Road South, Birmingham B31 2AP, England, UK
  • ,
  • A. Abudu

      Affiliations

    • Royal Orthopaedic Hospital NHS Trust, Bristol Road South, Birmingham B31 2AP, England, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 0 121 685 4037; fax: +44 0 121 685 4146.
  • ,
  • H. Murata

      Affiliations

    • Royal Orthopaedic Hospital NHS Trust, Bristol Road South, Birmingham B31 2AP, England, UK
    • Department of Orthopaedics, Graduate School of Medical Science, Kyoto Perfectural University of Medicine, Kyoto, Japan
  • ,
  • R.J. Grimer

      Affiliations

    • Royal Orthopaedic Hospital NHS Trust, Bristol Road South, Birmingham B31 2AP, England, UK
  • ,
  • R.M. Tillman

      Affiliations

    • Royal Orthopaedic Hospital NHS Trust, Bristol Road South, Birmingham B31 2AP, England, UK
  • ,
  • S.R. Carter

      Affiliations

    • Royal Orthopaedic Hospital NHS Trust, Bristol Road South, Birmingham B31 2AP, England, UK

Accepted 5 November 2009.

Abstract 

We present our experience of treating patients with tumours involving the whole femur with excision and total femur endoprostheses over the last 30 years (1975–2005). There were 26 consecutive patients (14 men and 12 women). Average age was 40 years (14–82 years) at the time of surgery and 21 of the patients had primary malignant bone tumours with five having the procedure for metastases. 11 patients were still alive of which nine were free of disease at the time of review at a mean follow-up of 57 months (3–348). The overall patient survival at 10 years was 37%. The survival of patients with a primary localised tumour was 50% at 10 years.

Revision of the prostheses was necessary in two patients (at 110 and 274 months) because of recurrent dislocation and aseptic loosening. Amputation was necessary in two patients but long term limb survival was 92% at 10 years. Nine patients alive with no evidence of disease had a mean MSTS functional score of 72%.

Keywords: Malignant tumours, Femur, Bone sarcoma, Sarcoma, Bone, Malignant, Primary tumour, Endoprosthetic replacement, Total femur replacement, Total femur, Limb salavage

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Level of Evidence – Therapeutic Study, Level – IV (Case series).

PII: S0748-7983(09)00504-6

doi:10.1016/j.ejso.2009.11.002

European Journal of Surgical Oncology
Volume 36, Issue 4 , Pages 378-383, April 2010